Clinical Trials Browser

Phase 1/2 × Pioglitazone × Clear all

NCT02767063 2020-08-07

ACTIW

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT01010243 2012-05-30

MM03

Phase 1/2 Unknown

Multiple Myeloma, Recurrence